CN107929696B - 一种消肿松肌正骨的外用中药组合物及其制备方法和应用 - Google Patents
一种消肿松肌正骨的外用中药组合物及其制备方法和应用 Download PDFInfo
- Publication number
- CN107929696B CN107929696B CN201711341181.4A CN201711341181A CN107929696B CN 107929696 B CN107929696 B CN 107929696B CN 201711341181 A CN201711341181 A CN 201711341181A CN 107929696 B CN107929696 B CN 107929696B
- Authority
- CN
- China
- Prior art keywords
- parts
- traditional chinese
- chinese medicine
- medicine composition
- sundew
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 62
- 239000000203 mixture Substances 0.000 title claims abstract description 56
- 210000000988 bone and bone Anatomy 0.000 title claims abstract description 39
- 230000008961 swelling Effects 0.000 title claims abstract description 39
- 210000003205 muscle Anatomy 0.000 title claims abstract description 38
- 230000002040 relaxant effect Effects 0.000 title claims abstract description 28
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- 235000008497 Drosera rotundifolia Nutrition 0.000 claims abstract description 41
- 239000000843 powder Substances 0.000 claims abstract description 41
- 239000002994 raw material Substances 0.000 claims abstract description 38
- 235000006886 Zingiber officinale Nutrition 0.000 claims abstract description 37
- 235000008397 ginger Nutrition 0.000 claims abstract description 37
- 235000004443 Ricinus communis Nutrition 0.000 claims abstract description 36
- 240000000528 Ricinus communis Species 0.000 claims abstract description 34
- 239000008159 sesame oil Substances 0.000 claims abstract description 26
- 235000011803 sesame oil Nutrition 0.000 claims abstract description 26
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 20
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 20
- 244000018716 Impatiens biflora Species 0.000 claims abstract description 20
- 235000015912 Impatiens biflora Nutrition 0.000 claims abstract description 20
- 235000005155 Tanacetum balsamita Nutrition 0.000 claims abstract description 20
- 241000830536 Tripterygium wilfordii Species 0.000 claims abstract description 20
- 239000000919 ceramic Substances 0.000 claims abstract description 20
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 20
- 235000011477 liquorice Nutrition 0.000 claims abstract description 20
- 150000003839 salts Chemical class 0.000 claims abstract description 20
- 235000015398 thunder god vine Nutrition 0.000 claims abstract description 20
- AXTGDCSMTYGJND-UHFFFAOYSA-N 1-dodecylazepan-2-one Chemical compound CCCCCCCCCCCCN1CCCCCC1=O AXTGDCSMTYGJND-UHFFFAOYSA-N 0.000 claims abstract description 19
- QMGVPVSNSZLJIA-UHFFFAOYSA-N Nux Vomica Natural products C1C2C3C4N(C=5C6=CC=CC=5)C(=O)CC3OCC=C2CN2C1C46CC2 QMGVPVSNSZLJIA-UHFFFAOYSA-N 0.000 claims abstract description 19
- 244000107975 Strychnos nux-vomica Species 0.000 claims abstract description 19
- 241001676573 Minium Species 0.000 claims abstract description 18
- 241000173529 Aconitum napellus Species 0.000 claims abstract description 13
- 241000725145 Homalomena Species 0.000 claims abstract description 13
- 229940023019 aconite Drugs 0.000 claims abstract description 13
- 241000218158 Clematis Species 0.000 claims abstract description 12
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 11
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 11
- 241000208698 Drosera Species 0.000 claims description 42
- 241000234314 Zingiber Species 0.000 claims description 36
- 238000010438 heat treatment Methods 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 16
- 238000002156 mixing Methods 0.000 claims description 16
- 238000002791 soaking Methods 0.000 claims description 14
- 206010003246 arthritis Diseases 0.000 claims description 8
- 241000903946 Clematidis Species 0.000 claims description 7
- 241000123866 Homalomena occulta Species 0.000 claims description 7
- 238000005303 weighing Methods 0.000 claims description 7
- 206010021118 Hypotonia Diseases 0.000 claims description 6
- 206010050296 Intervertebral disc protrusion Diseases 0.000 claims description 6
- 206010041591 Spinal osteoarthritis Diseases 0.000 claims description 6
- 208000036319 cervical spondylosis Diseases 0.000 claims description 6
- 208000005801 spondylosis Diseases 0.000 claims description 6
- 230000036640 muscle relaxation Effects 0.000 claims description 5
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 230000000699 topical effect Effects 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 25
- 230000017531 blood circulation Effects 0.000 abstract description 9
- 210000004369 blood Anatomy 0.000 abstract description 7
- 239000008280 blood Substances 0.000 abstract description 7
- 230000002829 reductive effect Effects 0.000 abstract description 7
- 208000006820 Arthralgia Diseases 0.000 abstract description 6
- 230000002195 synergetic effect Effects 0.000 abstract description 3
- 240000004551 Drosera rotundifolia Species 0.000 abstract 1
- 244000273928 Zingiber officinale Species 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 description 16
- 239000002674 ointment Substances 0.000 description 16
- 230000036407 pain Effects 0.000 description 15
- 229940079593 drug Drugs 0.000 description 11
- 238000007873 sieving Methods 0.000 description 10
- 239000011505 plaster Substances 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 230000001737 promoting effect Effects 0.000 description 7
- 210000003491 skin Anatomy 0.000 description 7
- 210000000952 spleen Anatomy 0.000 description 7
- 239000011248 coating agent Substances 0.000 description 6
- 238000000576 coating method Methods 0.000 description 6
- 230000001976 improved effect Effects 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 6
- 231100000331 toxic Toxicity 0.000 description 6
- 230000002588 toxic effect Effects 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 231100000419 toxicity Toxicity 0.000 description 5
- 230000001988 toxicity Effects 0.000 description 5
- 208000034656 Contusions Diseases 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 4
- 208000010040 Sprains and Strains Diseases 0.000 description 4
- 230000009519 contusion Effects 0.000 description 4
- 230000003467 diminishing effect Effects 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 235000019640 taste Nutrition 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 3
- 241000721047 Danaus plexippus Species 0.000 description 3
- 206010024453 Ligament sprain Diseases 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 208000005392 Spasm Diseases 0.000 description 3
- 239000004744 fabric Substances 0.000 description 3
- 208000034783 hypoesthesia Diseases 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 206010037844 rash Diseases 0.000 description 3
- 208000005198 spinal stenosis Diseases 0.000 description 3
- 210000000434 stratum corneum Anatomy 0.000 description 3
- 201000004595 synovitis Diseases 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- 208000008035 Back Pain Diseases 0.000 description 2
- 208000003044 Closed Fractures Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 240000007171 Imperata cylindrica Species 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 206010020718 hyperplasia Diseases 0.000 description 2
- 230000002390 hyperplastic effect Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000002147 killing effect Effects 0.000 description 2
- WABPQHHGFIMREM-UHFFFAOYSA-N lead(0) Chemical compound [Pb] WABPQHHGFIMREM-UHFFFAOYSA-N 0.000 description 2
- 239000010985 leather Substances 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000004745 nonwoven fabric Substances 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 235000019633 pungent taste Nutrition 0.000 description 2
- 210000000582 semen Anatomy 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 235000019605 sweet taste sensations Nutrition 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 231100000167 toxic agent Toxicity 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 208000010392 Bone Fractures Diseases 0.000 description 1
- 208000020084 Bone disease Diseases 0.000 description 1
- 206010005963 Bone formation increased Diseases 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 206010069729 Collateral circulation Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 206010013700 Drug hypersensitivity Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010017076 Fracture Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 206010023230 Joint stiffness Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 206010028836 Neck pain Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 208000007103 Spondylolisthesis Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 201000005311 drug allergy Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 210000001365 lymphatic vessel Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 201000000585 muscular atrophy Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 235000021251 pulses Nutrition 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000003307 reticuloendothelial effect Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 230000000276 sedentary effect Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000010891 toxic waste Substances 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/37—Celastraceae (Staff-tree or Bittersweet family), e.g. tripterygium or spindletree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/56—Loganiaceae (Logania family), e.g. trumpetflower or pinkroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/714—Aconitum (monkshood)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/716—Clematis (leather flower)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/0625—Warming the body, e.g. hyperthermia treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0659—Radiation therapy using light characterised by the wavelength of light used infrared
- A61N2005/066—Radiation therapy using light characterised by the wavelength of light used infrared far infrared
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pathology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Dermatology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种消肿松肌正骨的外用中药组合物及其制备方法,所述中药组合物包括以下重量份数配比的原料:马钱子3~7份、蓖麻子10~20份、茅膏菜6~10份、雪上一支蒿3~7份、干姜6~10份、甘草1~4份、千年健1~5份、透骨草1~3份、葛根1~5份、威灵仙1~5份、雷公藤1~5份、远红外陶瓷粉3~7份、氮酮1~5份、食盐0.3~0.7份、樟丹30~70份、芝麻油70~130份。本发明所提供的消肿松肌正骨的外用中药组合物通过优选以上成分的比例,使各成分之间协同作用、增强药效,减小副作用,可以温通经络、拔痹驱寒、活血化瘀、松弛肌肉,从而达到消肿松肌正骨的效果。
Description
技术领域
本发明涉及中药技术领域,特别涉及一种消肿松肌正骨的外用中药组合物及其制备方法和应用。
背景技术
现代人生活节奏快、压力大、久坐、长期使用手机和电脑,却往往缺乏锻炼,致使颈椎病、腰间盘突出、骨刺增生等疾病日间增多,且由于。而女性由于爱美,即使寒冷季节依然穿着单薄,从而导致膝关节炎的发生。另外,由于不科学的强度过高的锻炼或外力冲击所导致的滑膜炎、扭伤、挫伤、椎管狭窄、椎体滑脱、骨折等意外情况,也成为对于现代人的一大伤害。上述骨骼问题会使局部软组织、血管和淋巴管等受到不同程度的损伤,出现瘀血、疼痛、肿胀等症状,给伤者带来极大痛苦,甚至严重影响正常的生活和活动,降低了生活质量。由于伤者内损外伤,往往需要长期卧床,导致出现三根平衡失调、气血虚弱、关节僵滞、肌肉萎缩等情况。
发明内容
针对上述伤病、骨病会引起肿痛、骨骼异位的问题,本发明提供一种消肿松肌正骨的外用中药组合物。
以及,本发明还提供一种消肿松肌正骨的外用中药组合物的制备方法。
以及,本发明还提供一种消肿松肌正骨的外用中药组合物作为治疗颈椎病、腰间盘突出、增生骨刺、关节炎、滑膜炎、椎管狭窄、椎体滑脱、闭合性骨折、陈旧性扭伤、陈旧性挫伤药物的应用。
为达到上述发明目的,本发明实施例采用了如下的技术方案:
一种消肿松肌正骨的外用中药组合物,包括以下重量份数配比的原料:马钱子3~7份、蓖麻子10~20份、茅膏菜6~10份、雪上一支蒿3~7份、干姜6~10份、甘草1~4份、千年健1~5份、透骨草1~3份、葛根1~5份、威灵仙1~5份、雷公藤1~5份、远红外陶瓷粉3~7份、氮酮1~5份、食盐0.3~0.7份、樟丹30~70份、芝麻油70~130份。
相对于现有技术,本发明所提供的消肿松肌正骨的外用中药组合物通过优选以上成分的比例,使各成分之间协同作用、增强药效,减小副作用,可以温通经络、拔痹驱寒、活血化瘀、松弛肌肉,肿消、肌松而骨自正,从而达到消肿松肌正骨的技术效果。
本发明还提供了一种上述消肿松肌正骨的外用中药组合物的制备方法,所述消肿松肌正骨的外用中药组合物由所述原料经粉碎、浸泡、煎煮、收膏、混合而成。
该制备方法工序通过粉碎工序增加了药物的表面积,有助于有效成分的释放;通过浸泡工序,增加了固体原料与芝麻油的接触时间,提高了有效成分的提取效果;通过增加了药物煎煮工序,促进有效成分的释放,显著提高了煎煮原料中有效成分的生物利用度,更易于吸收并发挥效果;通过收膏工序,得到膏药基质,可以作为主药的载体,并方便于临床使用。
本发明还提供了上述消肿松肌正骨的外用中药组合物作为治疗颈椎病、腰间盘突出、增生骨刺、关节炎、滑膜炎、椎管狭窄、椎体滑脱、闭合性骨折、陈旧性扭伤、陈旧性挫伤药物的应用。
本发明通过活血通络来消肿止痛、松弛肌肉,从而使骨骼自正、患处逐渐自愈,减轻或消除患者痛苦。
具体实施方式
为了使本发明的目的、技术方案及优点更加清楚明白,以下结合具体实施例,对本发明进行进一步详细说明。应当理解,此处所描述的具体实施例仅仅用以解释本发明,并不用于限定本发明。
本发明实施例提供一种消肿松肌正骨的外用中药组合物,包括以下重量份数配比的原料:马钱子3~7份、蓖麻子10~20份、茅膏菜6~10份、雪上一支蒿3~7份、干姜6~10份、甘草1~4份、千年健1~5份、透骨草1~3份、葛根1~5份、威灵仙1~5份、雷公藤1~5份、远红外陶瓷粉3~7份、氮酮1~5份、食盐0.3~0.7份、樟丹30~70份、芝麻油70~130份。
相对于现有技术,本发明所提供的消肿松肌正骨的外用中药组合物通过优选以上成分的比例,使各成分之间协同作用、增强药效,减小副作用,可以温通经络、拔痹驱寒、活血化瘀、松弛肌肉,从而达到消肿松肌正骨的技术效果。
马钱子味苦,性温,有大毒,归肝、脾经,兴奋健胃,凉血,通经络,消肿止痛,主治四肢麻木,瘫痪,痈疮肿毒等;蓖麻子可拔毒、泻下通滞,主治痈疽肿毒、瘰疬、水肿腹满,大便燥结等,善于拔陈病;茅膏菜味甘辛、性平,可治疗陈旧性的扭挫伤疼痛,但全草有毒,叶的水浸液触及皮肤,可引起灼痛、发炎;雪上一支蒿味苦、辛,性温,可治疗骨折肿痛,但有大毒。在本发明所述中药组合物中,马钱子、雪上一枝蒿、茅膏菜、蓖麻子共为君,有消肿散瘀活血止痛的作用。单独使用茅膏菜,容易造成皮肤起水泡;单独使用雪上一枝蒿,容易造成药物过敏。在本发明的中药组合物中,君药与臣药、佐药诸方合用,可以减小君药的毒副作用,并提高药效,且疗效确切。
进一步优选地,所述茅膏菜为茅膏菜的根部和/或全草。茅膏菜的根部为陈伤子,可以清热利湿、祛风除湿、行血止痛,用于筋骨疼痛、腰痛、偏头痛、跌打损伤等,特别对于年长患者,有更明显的消肿止痛松肌的作用。
干姜味辛,性热,归脾、胃、肾、心、肺经,温中散寒,回阳通脉,温肺化饮,用于脘腹冷痛,呕吐泄泻,肢冷脉微,寒饮喘咳;甘草味甘,性平,归心、肺、脾、胃经,补脾益气,清热解毒,祛痰止咳,缓急止痛,调和诸药,用于脾胃虚弱、倦怠乏力、心悸气短、四肢挛急疼痛,痈肿疮毒等,可缓解药物毒性、烈性。在本发明所述中药组合物中,干姜、甘草为臣,用于抗过敏解毒的功效。
千年健味苦、辛,性温,归肝、肾经,有祛风湿,壮筋骨的功效,用于风寒湿痹,腰膝冷痛,拘挛麻木,筋骨痿软;透骨草味甘、辛,性温,归入肺、肝经,祛风除湿、舒筋活络、活血止痛、解毒化疹;雷公藤苦、辛,凉。有大毒,祛风除湿,活血通络,消肿止痛,杀虫解毒。在本发明所述中药组合物中,千年健、雷公藤、透骨草为佐,有祛风除湿的功效。
葛根味甘、辛,性凉,归肺、胃经,解肌退热,透疹,生津止渴,升阳止泻,用于表证发热、项背强痛、麻疹不透、热病口渴、阴虚消渴、热泻热痢、脾虚泄泻。
威灵仙味辛、咸,性温,归膀胱经,有祛风湿,通经络的作用,用于风湿痹痛,肢体麻木,筋脉拘挛,屈伸不利。
远红外陶瓷粉能够辐射出比正常物体更多的远红外线,远红外线的热作用通过神经液的回答反应激活了免疫细胞功能,加强了白细胞和网状内皮细胞的吞噬功能,达到消炎抑菌的目的,具有消炎功能;改善了微循环、建立了侧枝循环、调节了离子的深度、促进了有毒物质的代谢、废物的排泄、加速了渗出物质的吸收,具有消肿功能。
氮酮对亲油、亲水性药物的活性成分有明显的透皮助渗作用,使皮肤角质层与脂质相互作用,降低了有效物质向角质层间隙中脂质的相转移温度,增加了流动性,使药物或活性添加剂在角质层中的扩散阻力减少,故起到很强的促渗作用,使药物更容易吸收。
食盐在维持渗透压方面起着重要作用,影响着人体内水的动向,可以促进有效成分的吸收。食盐除具有较强的杀虫灭菌消炎作用外,还具有深层清洁、杀菌排毒、舒经活血的作用,可以清热解毒、凉血润燥。
樟丹味辛、微寒、有毒,有解热、拔毒的功效。
芝麻油具有抗氧化性,加热后抗氧化性增强。芝麻油作为浸出原料的溶剂,可以促进原料中脂溶性成分的溶出;且芝麻油不易干燥,可使膏体长时间保持原有形态;芝麻油中加入樟丹后再加热,即可制得膏体基质。
本发明实施例还提供一种上述消肿松肌正骨的外用中药组合物的制备方法,所述消肿松肌正骨的外用中药组合物由所述原料经粉碎、浸泡、煎煮、收膏、混合而成。
该制备方法工序通过粉碎工艺,增加了药物的表面积,更有利于有效成分的释放;通过浸泡工艺,使原料与芝麻油充分接触,提高后续的提取率;通过煎煮工序,极大的提高了煎煮原料中有效成分的生物利用度,更易于吸收并发挥效果;通过收膏,将混合料液制成基质,便于载药和涂敷。
具体地,上述制备方法具体包括以下步骤:
步骤a、按原料配比称取各原料组分,将蓖麻子、干姜、茅膏菜粉碎,得蓖麻籽粉、干姜粉、茅膏菜粉;
步骤b、将马钱子、蓖麻子、雪上一枝高、甘草、千年健、透骨草、葛根、威灵仙、雷公藤加入芝麻油中浸泡后煎煮;
步骤c、加入樟丹混合并加热,制成膏状,加入远红外陶瓷粉、氮酮、茅膏菜粉、干姜粉、食盐,混合,即得。
进一步优选的,步骤a中所述粉碎为:干姜、茅膏菜粉碎至100~200目,蓖麻子粉碎至40~80目。蓖麻子粉碎之后更容易使芝麻油浸润,从而提高提取率。干姜与茅膏菜为后加,粉碎至优选的粒度范围可以使最终所得膏状成品更细腻,增加患者使用舒适度,并且该粒度范围有利于干姜与茅膏菜中有效成分的释放.
进一步优选的,步骤b中所述浸泡为3~10天,充分的浸泡可以增加原料与芝麻油的接触时间,使芝麻油更充分地浸润原料,有利于原料中有效成分的溶出。所述煎煮为1~1.2小时,优选的煎煮时间可以对原料进行较为充分的提取,煎煮时间太短则提取率低,煎煮超过优选的时间之后对提取率没有明显提高,但增加了时间成本。
进一步优选的,步骤c中所述加热为加热至280~320℃,在优选的温度下,煎煮后的混合液可以更快收膏,成为适合使用的基质。
为了更好的说明本发明实施方式,下面通过实施例做进一步的举例说明。
实施例1
本发明实施例提供了一种消肿松肌正骨的外用中药组合物,包括以下重量份数配比的原料:马钱子3份、蓖麻子10份、茅膏菜(全草)6份、雪上一支蒿3份、干姜6份、甘草1份、千年健1份、透骨草1份、葛根1份、威灵仙1份、雷公藤1份、远红外陶瓷粉3份、氮酮1份、食盐0.3份、樟丹30份、芝麻油70份。
制备方法:
步骤a、按原料配比称取各原料组分,将干姜、茅膏菜(全草)粉碎过100目筛,蓖麻子粉碎过40目筛;
步骤b、将马钱子、蓖麻子、雪上一枝高、甘草、千年健、透骨草、葛根、威灵仙、雷公藤加入芝麻油中浸泡10天后煎煮1.2小时;
步骤c、加入樟丹混合并加热至280℃,将混合物制成膏状,加入远红外陶瓷粉、氮酮、茅膏菜(全草)粉、干姜粉、食盐,混合,即得。
使用方法:将步骤c所得膏状混合物加热至50~70℃,涂于棉布上制成贴膏;临用时,用酒精灯加热至40~50℃,趁热敷于患处皮肤,每4日更换一次。
实施例2
本发明实施例提供了一种消肿松肌正骨的外用中药组合物,包括以下重量份数配比的原料:马钱子4份、蓖麻子12份、茅膏菜(根部)7份、雪上一支蒿4份、干姜7份、甘草1份、千年健2份、透骨草1份、葛根2份、威灵仙2份、雷公藤2份、远红外陶瓷粉4份、氮酮2份、食盐0.4份、樟丹40份、芝麻油80份。
制备方法:
步骤a、按原料配比称取各原料组分,将干姜、茅膏菜(根部)粉碎过120目筛,蓖麻子粉碎过60目筛;
步骤b、将马钱子、蓖麻子、雪上一枝高、甘草、千年健、透骨草、葛根、威灵仙、雷公藤加入芝麻油中浸泡7天后煎煮1.2小时;
步骤c、加入樟丹混合并加热至300℃,将混合物制成膏状,加入远红外陶瓷粉、氮酮、茅膏菜(根部)粉、干姜粉、食盐,混合即得。
使用方法:将步骤c所得膏状混合物加热至50~70℃,涂于革布上制成贴膏;临用时,用酒精灯加热至40~50℃,趁热敷于患处皮肤,每5日更换一次。
实施例3
本发明实施例提供了一种消肿松肌正骨的外用中药组合物,包括以下重量份数配比的原料:马钱子5份、蓖麻子15份、茅膏菜(全草)8份、雪上一支蒿5份、干姜8份、甘草2份、千年健3份、透骨草1.5份、葛根3份、威灵仙3份、雷公藤3份、远红外陶瓷粉5份、氮酮3份、食盐0.5份、樟丹50份、芝麻油100份。
制备方法:
步骤a、按原料配比称取各原料组分,将干姜、茅膏菜(全草)粉碎过140目筛,蓖麻子粉碎过70目筛;
步骤b、将马钱子、蓖麻子、雪上一枝高、甘草、千年健、透骨草、葛根、威灵仙、雷公藤加入芝麻油中浸泡5天后煎煮1小时;
步骤c、加入樟丹混合并加热至300℃,将混合物制成膏状,加入远红外陶瓷粉、氮酮、茅膏菜(全草)粉、干姜粉、食盐,混合即得。
使用方法:将步骤c所得膏状混合物加热至50~70℃,涂于无纺布上制成贴膏;临用时,用酒精灯加热至40~50℃,趁热敷于患处皮肤,每6日更换一次。
实施例4
本发明实施例提供了一种消肿松肌正骨的外用中药组合物,包括以下重量份数配比的原料:马钱子6份、蓖麻子18份、茅膏菜(地上部分)9份、雪上一支蒿6份、干姜9份、甘草3份、千年健4份、透骨草2份、葛根4份、威灵仙4份、雷公藤4份、远红外陶瓷粉6份、氮酮4份、食盐0.6份、樟丹60份、芝麻油120份。
制备方法:
步骤a、按原料配比称取各原料组分,将干姜、茅膏菜(地上部分)粉碎过160目筛,蓖麻子粉碎过80目筛;
步骤b、将马钱子、蓖麻子、雪上一枝高、甘草、千年健、透骨草、葛根、威灵仙、雷公藤加入芝麻油中浸泡5天后煎煮1小时;
步骤c、加入樟丹混合并加热至300℃,将混合物制成膏状,加入远红外陶瓷粉、氮酮、茅膏菜(地上部分)粉、干姜粉、食盐,混合即得。
使用方法:将步骤c所得膏状混合物加热至50~70℃,涂于无纺布上制成贴膏;临用时,用酒精灯加热至40~50℃,趁热敷于患处皮肤,每4日更换一次。
实施例5
本发明实施例提供了一种消肿松肌正骨的外用中药组合物,包括以下重量份数配比的原料:马钱子7份、蓖麻子20份、茅膏菜(全草)10份、雪上一支蒿7份、干姜10份、甘草4份、千年健5份、透骨草3份、葛根5份、威灵仙5份、雷公藤5份、远红外陶瓷粉7份、氮酮5份、食盐0.7份、樟丹70份、芝麻油130份。
制备方法:
步骤a、按原料配比称取各原料组分,将干姜、茅膏菜(全草)粉碎过200目筛,蓖麻子粉碎过80目筛;
步骤b、将马钱子、蓖麻子、雪上一枝高、甘草、千年健、透骨草、葛根、威灵仙、雷公藤加入芝麻油中浸泡3天后煎煮1.2小时;
步骤c、加入樟丹混合并加热至320℃,将混合物制成膏状,加入远红外陶瓷粉、氮酮、茅膏菜(全草)粉、干姜粉、食盐,混合即得。
使用方法:将步骤c所得膏状混合物加热至50~70℃,涂于革布上制成贴膏;临用时,用酒精灯加热至40~50℃,趁热敷于患处皮肤,每5日更换一次。
临床试验
试验对象:颈椎病患者20例,35~45岁;腰间盘突出患者20例,35~45岁;膝关节炎一组患者20例,40~55岁;膝关节炎二组患者20例,30~40岁。
试验材料:实施例3所得消肿松肌正骨的外用中药组合物。
6日、12日、30日后对临床试验结果进行统计,记录有效例数,结果见表1。
表1症状观察表
由以上临床试验数据可见,本发明实施例3所提供的消肿松肌正骨的外用中药组合物治疗颈椎病一个月的有效率达95%,治疗腰椎间盘突出的有效率达70%,治疗老年膝关节炎患者一个月的有效率达65%,治疗中年膝关节炎患者6日有效率达90%,12日全部治愈。
以上所述仅为本发明的较佳实施例而已,并不用以限制本发明,凡在本发明的精神和原则之内所作的任何修改、等同替换或改进等,均应包含在本发明的保护范围之内。
Claims (9)
1.一种消肿松肌正骨的外用中药组合物,其特征在于:由以下重量份数配比的原料制成:马钱子3~7份、蓖麻子10~20份、茅膏菜6~10份、雪上一支蒿3~7份、干姜6~10份、甘草1~4份、千年健1~5份、透骨草1~3份、葛根1~5份、威灵仙1~5份、雷公藤1~5份、远红外陶瓷粉3~7份、氮酮1~5份、食盐0.3~0.7份、樟丹30~70份、芝麻油70~130份。
2.根据权利要求1所述的消肿松肌正骨的外用中药组合物,其特征在于:由以下重量份数配比的原料制成:马钱子4~6份、蓖麻子12~18份、茅膏菜7~9份、雪上一支蒿4~6份、干姜7~9份、甘草1~3份、千年健2~4份、透骨草1~2份、葛根2~4份、威灵仙2~4份、雷公藤2~4份、远红外陶瓷粉4~6份、氮酮2~4份、食盐0.4~0.6份、樟丹40~60份、芝麻油80~120份。
3.根据权利要求2所述的消肿松肌正骨的外用中药组合物,其特征在于:由以下重量份数配比的原料制成:马钱子5份、蓖麻子15份、茅膏菜8份、雪上一支蒿5份、干姜8份、甘草2份、千年健3份、透骨草1.5份、葛根3份、威灵仙3份、雷公藤3份、远红外陶瓷粉5份、氮酮3份、食盐0.5份、樟丹50份、芝麻油100份。
4.根据权利要求1-3任一项所述的消肿松肌正骨的外用中药组合物,其特征在于:所述茅膏菜为茅膏菜的根部和/或全草。
5.一种权利要求1-3任一项所述的消肿松肌正骨的外用中药组合物的制备方法,其特征在于,包括以下步骤:
步骤a、按原料配比称取各原料组分,将蓖麻子、茅膏菜、干姜粉碎,得蓖麻子粉、茅膏菜粉、干姜粉;
步骤b、将马钱子、蓖麻子粉、雪上一枝高、甘草、千年健、透骨草、葛根、威灵仙、雷公藤加入芝麻油中浸泡后煎煮;
步骤c、加入樟丹混合并加热,制成膏状,加入远红外陶瓷粉、氮酮、茅膏菜粉、干姜粉、食盐,混合,即得。
6.根据权利要求5所述的消肿松肌正骨的外用中药组合物的制备方法,其特征在于,所述步骤a中所述粉碎为:干姜、茅膏菜粉碎至100~200目,蓖麻子粉碎至40~80目。
7.根据权利要求5所述的消肿松肌正骨的外用中药组合物的制备方法,其特征在于,所述步骤b中所述浸泡为3~10天;和/或
所述步骤b中所述煎煮为1~1.2小时。
8.根据权利要求5所述的消肿松肌正骨的外用中药组合物的制备方法,其特征在于,所述步骤c中所述加热为加热至280~320℃。
9.权利要求1-3任一项所述消肿松肌正骨的外用中药组合物在制备治疗颈椎病、腰间盘突出、关节炎药物中的应用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711341181.4A CN107929696B (zh) | 2017-12-14 | 2017-12-14 | 一种消肿松肌正骨的外用中药组合物及其制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711341181.4A CN107929696B (zh) | 2017-12-14 | 2017-12-14 | 一种消肿松肌正骨的外用中药组合物及其制备方法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107929696A CN107929696A (zh) | 2018-04-20 |
CN107929696B true CN107929696B (zh) | 2020-10-23 |
Family
ID=61944259
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711341181.4A Active CN107929696B (zh) | 2017-12-14 | 2017-12-14 | 一种消肿松肌正骨的外用中药组合物及其制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107929696B (zh) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007112963A1 (en) * | 2006-03-31 | 2007-10-11 | Dsm Ip Assets B.V. | Novel use of ascorbigen |
CN101912572B (zh) * | 2010-07-30 | 2012-06-27 | 崔宝海 | 一种多效外用膏药 |
CN105709021A (zh) * | 2016-03-14 | 2016-06-29 | 张春荣 | 一种筋骨复原膏及其制备方法 |
-
2017
- 2017-12-14 CN CN201711341181.4A patent/CN107929696B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN107929696A (zh) | 2018-04-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103705670A (zh) | 一种祛风除湿止痛的中药及其制备方法 | |
CN104815295A (zh) | 一种治疗颈椎病的中药制剂 | |
CN101954053B (zh) | 一种中药贴剂及其制备方法 | |
CN101301406B (zh) | 治疗骨质增生、椎间盘突出以及颈椎炎、风湿关节炎的外敷剂 | |
CN100431577C (zh) | 一种治疗股骨头坏死、股骨颈骨折的药物及其制备方法 | |
CN101905011A (zh) | 一种用于治疗颈椎病的中药组合物 | |
CN107007724B (zh) | 一种中药保健液及其制备方法 | |
CN102626505A (zh) | 基于中草药的按摩膏及其制备方法 | |
CN104189839B (zh) | 一种主治半身不遂的灸条及制作方法和灸疗方法 | |
CN104056076A (zh) | 一种健骨药酒 | |
CN107929696B (zh) | 一种消肿松肌正骨的外用中药组合物及其制备方法和应用 | |
CN104623617B (zh) | 一种治疗骨关节疾病的药物及其制备方法和使用方法 | |
CN103751626A (zh) | 一种治疗坐骨神经痛的中药制剂及制备方法 | |
CN106215051A (zh) | 一种治疗周围神经损伤的中西复方药物及制备方法 | |
CN102949544B (zh) | 专治偏瘫病人手足肿胀的中药组合物 | |
CN112386669A (zh) | 一种活血化瘀、舒筋活络的草本植物活络膏及其制备方法 | |
CN112107666A (zh) | 一种药灸治疗用中药组合物及其制备方法和应用 | |
CN1315516C (zh) | 一种治疗风湿病的药物 | |
CN105561270A (zh) | 一种外敷止痛中草药及其制备方法 | |
CN106421255B (zh) | 一种外用中草药组合物及其应用 | |
CN110946932A (zh) | 灸疗组合物及其制备方法和应用 | |
CN109793849A (zh) | 一种祛痛保健贴 | |
CN109289020A (zh) | 中医穴位磁热定向透药 | |
CN109394928A (zh) | 一种艾灸液及其制备方法 | |
CN109172786A (zh) | 一种祛湿祛寒的草本能量泥配方及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |